
Debiganto 75mg Tablet
Marketer
Shinto Organics (P) Limited
Salt Composition
Dabigatran Etexilate (75mg)
Overview Debiganto 75mg Tablet
Anticoagulant medication, Debiganto 75mg Tablet, thins the blood, preventing and treating blood clots. This reduces the risk of stroke and heart attack, preventing clot formation in leg, lung, brain, and heart veins. Frequently prescribed for atrial fibrillation to inhibit clot formation, it also lowers clot risk post-knee or hip replacement. Administration is flexible – with or without food – but consistent daily timing is recommended. Long-term use, sometimes lifelong, may be necessary; discontinuation or dosage alteration requires physician approval to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications – such as abstaining from smoking, adopting a healthy diet, exercising regularly, and managing weight – further minimize clot risk. Common side effects include gastrointestinal upset and increased bleeding tendency (e.g., nosebleeds, bruising). Report any symptoms promptly. Additional potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindicated in cases of severe hepatic or renal impairment, active bleeding, or concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike many anticoagulants, routine PT-INR monitoring isn't mandated.
Uses of Debiganto 75mg Tablet
Preventing and managing blood clots
Major Benefits of Debiganto 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Debiganto 75mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Debiganto 75mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Debiganto 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Debiganto 75mg Tablets. Swallow the tablet whole; do not crush, chew, or break it. While you can take it with or without food, consistency is key – take it at the same time each day.
How Debiganto 75mg Tablet works:
Novocoag 75mg tablets represent a new class of oral anticoagulants, effectively inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Debiganto 75mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Pregnant women may not be able to safely take Debiganto 75mg Tablets. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of 75mg Debiganto tablets are likely incompatible. Available human data indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Debiganto 75mg Tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Debiganto 75mg tablets, potentially requiring dosage modification under medical supervision. Debiganto 75mg tablets are unsuitable for individuals with severely compromised kidney function.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Debiganto 75mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Debiganto 75mg Tablet :
Should you forget a dose of your Debiganto 75mg Tablet, administer it as quickly as possible that day. However, omit the missed dose if it's less than 6 hours until your next scheduled intake. Never take a double dose to compensate for a missed one.
Facts to Know About Debiganto 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Oral direct thrombin inhibitor |
